These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 10613621)
21. Theophylline pharmacokinetics are not altered by lansoprazole in CYP2C19 poor metabolizers. Ko JW; Jang IJ; Shin JG; Nam SK; Shin SG; Flockhart DA Clin Pharmacol Ther; 1999 Jun; 65(6):606-14. PubMed ID: 10391666 [TBL] [Abstract][Full Text] [Related]
22. CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans. Furuta T; Ohashi K; Kosuge K; Zhao XJ; Takashima M; Kimura M; Nishimoto M; Hanai H; Kaneko E; Ishizaki T Clin Pharmacol Ther; 1999 May; 65(5):552-61. PubMed ID: 10340921 [TBL] [Abstract][Full Text] [Related]
23. Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy. Odani A; Hashimoto Y; Otsuki Y; Uwai Y; Hattori H; Furusho K; Inui K Clin Pharmacol Ther; 1997 Sep; 62(3):287-92. PubMed ID: 9333104 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and pharmacodynamics of etizolam are influenced by polymorphic CYP2C19 activity. Fukasawa T; Yasui-Furukori N; Suzuki A; Inoue Y; Tateishi T; Otani K Eur J Clin Pharmacol; 2005 Dec; 61(11):791-5. PubMed ID: 16261363 [TBL] [Abstract][Full Text] [Related]
25. Effects of CYP2C19 genetic polymorphism on the pharmacokinetics and pharmacodynamics of omeprazole in Chinese people. Hu XP; Xu JM; Hu YM; Mei Q; Xu XH J Clin Pharm Ther; 2007 Oct; 32(5):517-24. PubMed ID: 17875119 [TBL] [Abstract][Full Text] [Related]
26. Bantu Tanzanians have a decreased capacity to metabolize omeprazole and mephenytoin in relation to their CYP2C19 genotype. Herrlin K; Massele AY; Jande M; Alm C; Tybring G; Abdi YA; Wennerholm A; Johansson I; Dahl ML; Bertilsson L; Gustafsson LL Clin Pharmacol Ther; 1998 Oct; 64(4):391-401. PubMed ID: 9797796 [TBL] [Abstract][Full Text] [Related]
27. Clearance of diazepam can be impaired by its major metabolite desmethyldiazepam. Klotz U; Reimann I Eur J Clin Pharmacol; 1981; 21(2):161-3. PubMed ID: 6804244 [TBL] [Abstract][Full Text] [Related]
28. Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humans. Furuta T; Ohashi K; Kobayashi K; Iida I; Yoshida H; Shirai N; Takashima M; Kosuge K; Hanai H; Chiba K; Ishizaki T; Kaneko E Clin Pharmacol Ther; 1999 Sep; 66(3):265-74. PubMed ID: 10511062 [TBL] [Abstract][Full Text] [Related]
29. CYP2C19 polymorphism affects single-dose pharmacokinetics of oral pantoprazole in healthy volunteers. GawroĊska-Szklarz B; Adamiak-Giera U; Wyska E; Kurzawski M; Gornik W; Kaldonska M; Drozdzik M Eur J Clin Pharmacol; 2012 Sep; 68(9):1267-74. PubMed ID: 22418828 [TBL] [Abstract][Full Text] [Related]
30. [Comparison of genetic polymorphism of cytochrome CYP2C19 between men and women in Chinese population]. Fu LQ; Huang F; Wu DZ; Guo JH Yao Xue Xue Bao; 2004 Mar; 39(3):161-3. PubMed ID: 15171646 [TBL] [Abstract][Full Text] [Related]
31. Ciprofloxacin does not impair the elimination of diazepam in humans. Wijnands WJ; Trooster JF; Teunissen PC; Cats HA; Vree TB Drug Metab Dispos; 1990; 18(6):954-7. PubMed ID: 1981543 [TBL] [Abstract][Full Text] [Related]
32. Serum medazepam, diazepam, and N-desmethyldiazepam levels after single and multiple oral doses of medazepam. Viukari M; Linnoila M Ann Clin Res; 1977 Oct; 9(5):284-6. PubMed ID: 28686 [TBL] [Abstract][Full Text] [Related]
33. Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes. Takahashi H; Kashima T; Nomizo Y; Muramoto N; Shimizu T; Nasu K; Kubota T; Kimura S; Echizen H Clin Pharmacol Ther; 1998 May; 63(5):519-28. PubMed ID: 9630825 [TBL] [Abstract][Full Text] [Related]
34. Effects of omeprazole on intragastric pH and plasma gastrin are dependent on the CYP2C19 polymorphism. Sagar M; Tybring G; Dahl ML; Bertilsson L; Seensalu R Gastroenterology; 2000 Sep; 119(3):670-6. PubMed ID: 10982760 [TBL] [Abstract][Full Text] [Related]
35. Slow chloroguanide metabolism in Tanzanians compared with white subjects and Asian subjects confirms a decreased CYP2C19 activity in relation to genotype. Herrlin K; Massele AY; Rimoy G; Alm C; Rais M; Ericsson O; Bertilsson L; Gustafsson LL Clin Pharmacol Ther; 2000 Aug; 68(2):189-98. PubMed ID: 10976550 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of diazepam metabolism by fluvoxamine: a pharmacokinetic study in normal volunteers. Perucca E; Gatti G; Cipolla G; Spina E; Barel S; Soback S; Gips M; Bialer M Clin Pharmacol Ther; 1994 Nov; 56(5):471-6. PubMed ID: 7955810 [TBL] [Abstract][Full Text] [Related]
37. How to correctly calculate the proportions of the heterozygotes and homozygotes in the extensive metabolizers of a certain drug-metabolizing enzyme in an ethnic or racial population? Xie HG Clin Pharmacol Ther; 1998 Nov; 64(5):575. PubMed ID: 9834051 [No Abstract] [Full Text] [Related]
38. Pharmacokinetics of three proton pump inhibitors in Chinese subjects in relation to the CYP2C19 genotype. Qiao HL; Hu YR; Tian X; Jia LJ; Gao N; Zhang LR; Guo YZ Eur J Clin Pharmacol; 2006 Feb; 62(2):107-12. PubMed ID: 16402242 [TBL] [Abstract][Full Text] [Related]
39. CYP2C19 genotype and S-mephenytoin 4'-hydroxylation phenotype in a Chinese Dai population. He N; Yan FX; Huang SL; Wang W; Xiao ZS; Liu ZQ; Zhou HH Eur J Clin Pharmacol; 2002 Apr; 58(1):15-8. PubMed ID: 11956668 [TBL] [Abstract][Full Text] [Related]
40. Disposition of diazepam in young and elderly subjects after acute and chronic dosing. Herman RJ; Wilkinson GR Br J Clin Pharmacol; 1996 Aug; 42(2):147-55. PubMed ID: 8864311 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]